Crossmark

SGLT2 inhibitors in peritoneal dialysis: a promising frontier toward improved patient outcomes

Crossref DOI link: https://doi.org/10.1186/s41100-024-00523-5

Published Online: 2024-01-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stepanova, Natalia http://orcid.org/0000-0002-1070-3602
License Information

Text and Data Mining valid from 2024-01-31

Version of Record valid from 2024-01-31
More Information

Article History

Received: 14 December 2023

Accepted: 14 January 2024

First Online: 31 January 2024

Declarations

:

: Not applicable.

: Not applicable.

: The author declares no conflict of interest.